RCE.AX
Price:
$0.475
Market Cap:
$110.14M
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.[Read more]
Industry
Biotechnology
IPO Date
2016-01-14
Stock Exchange
ASX
Ticker
RCE.AX
According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current ROE is 392.94%. This represents a change of -183.33% compared to the average of -471.56% of the last 4 quarters.
The mean historical ROE of Recce Pharmaceuticals Ltd over the last ten years is 11.56%. The current 392.94% ROE has changed 3.30% with respect to the historical average. Over the past ten years (40 quarters), RCE.AX's ROE was at its highest in in the June 2019 quarter at 425.02%. The ROE was at its lowest in in the December 2023 quarter at -1396.87%.
Average
11.56%
Median
-87.55%
Minimum
-512.67%
Maximum
687.67%
Discovering the peaks and valleys of Recce Pharmaceuticals Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.34%
Maximum Annual ROE = 687.67%
Minimum Annual Increase = -562.62%
Minimum Annual ROE = -512.67%
Year | ROE | Change |
---|---|---|
2024 | 185.45% | -63.29% |
2023 | 505.15% | -562.62% |
2022 | -109.19% | 65.68% |
2021 | -65.91% | -64.69% |
2020 | -186.66% | -127.14% |
2019 | 687.67% | -385.42% |
2018 | -240.93% | -53.00% |
2017 | -512.67% | 272.17% |
2016 | -137.75% | 1.34% |
2015 | -9.55% | -101.97% |
The current ROE of Recce Pharmaceuticals Ltd (RCE.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
193.80%
5-year avg
65.77%
10-year avg
11.56%
Recce Pharmaceuticals Ltd’s ROE is greater than Orthocell Limited (-214.01%), greater than Race Oncology Limited (-71.34%), greater than Paradigm Biopharmaceuticals Limited (-203.64%), less than Opthea Limited (520.65%), greater than Mach7 Technologies Limited (-19.36%),
Company | ROE | Market cap |
---|---|---|
-214.01% | $340.38M | |
-71.34% | $222.35M | |
-203.64% | $163.56M | |
520.65% | $923.44M | |
-19.36% | $82.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Recce Pharmaceuticals Ltd's ROE?
How is the ROE calculated for Recce Pharmaceuticals Ltd (RCE.AX)?
What is the highest ROE for Recce Pharmaceuticals Ltd (RCE.AX)?
What is the 3-year average ROE for Recce Pharmaceuticals Ltd (RCE.AX)?
What is the 5-year average ROE for Recce Pharmaceuticals Ltd (RCE.AX)?
How does the current ROE for Recce Pharmaceuticals Ltd (RCE.AX) compare to its historical average?